Follow
Daniel Sabanes Bove
Daniel Sabanes Bove
Verified email at roche.com - Homepage
Title
Cited by
Cited by
Year
Applied Statistical Inference: Likelihood and Bayes
L Held, D Sabanés Bové
Berlin, Heidelberg: Springer Berlin Heidelberg, 2014
263*2014
Software for Bayesian Inference in Structured Additive Regression Models
C Belitz, A Brezger, T Kneib, S Lang, EM Fronk, F Heinzl, A Hennerfeind, ...
178*
Hyper-g priors for generalized linear models
D Sabanés Bové, L Held
Bayesian Analysis 6 (3), 387-410, 2011
1292011
Reduction of Thromboembolic Events in Meningioma Surgery: A Cohort Study of 724 Consecutive Patients
CV Eisenring, MC Neidert, DS Bové, L Held, J Sarnthein, N Krayenbühl
PLOS ONE 8 (11), e79170, 2013
472013
Pilot study on HTR2A promoter polymorphism,− 1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive–compulsive …
S Walitza, DS Bové, M Romanos, T Renner, L Held, M Simons, ...
Journal of Neural Transmission 119, 507-515, 2012
472012
Likelihood and Bayesian inference: with applications in biology and medicine
L Held, DS Bové
Springer Nature, 2020
36*2020
Bayesian fractional polynomials
DS Bové, L Held
Statistics and Computing 21 (3), 309-324, 2011
342011
Sensitization to Common Ragweed in Southern Bavaria: Clinical and Geographical Risk Factors in Atopic Patients
F Ruëff, B Przybilla, A Walker, J Gmeiner, M Kramer, D Sabanés-Bové, ...
International Archives of Allergy and Immunology 159 (1), 65-74, 2012
322012
Approximate Bayesian model selection with the deviance statistic
L Held, DS Bové, I Gravestock
Statistical Science 30 (2), 242-257, 2015
272015
Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with …
G Argiles, J Saro, NH Segal, I Melero, W Ros, A Marabelle, ME Rodriguez, ...
Annals of Oncology 28, iii151, 2017
262017
Objective Bayesian Model Selection in Generalised Additive Models with Penalised Splines
DS Bové, L Held, G Kauermann
Journal of Computational and Graphical Statistics, 00-00, 2014
20*2014
Objective Bayesian model selection for Cox regression
L Held, I Gravestock, D Sabanés Bové
Statistics in Medicine 35 (29), 5376-5390, 2016
172016
Bayesian adaptive dose‐escalation designs for simultaneously estimating the optimal and maximum safe dose based on safety and efficacy
WY Yeung, B Reigner, U Beyer, C Diack, D Sabanés bové, G Palermo, ...
Pharmaceutical statistics 16 (6), 396-413, 2017
132017
Validating and updating a risk model for pneumonia–a case study
U Held, D Bové, J Steurer, L Held
BMC Medical Research Methodology 12 (1), 99, 2012
122012
Model-Based Dose Escalation Designs in R with crmPack
D Sabanés Bové, WY Yeung, G Palermo, T Jaki
Journal of Statistical Software 89 (10), 2019
112019
Choice of generalized linear mixed models using predictive crossvalidation
J Braun, D Sabanés Bové, L Held
Computational Statistics & Data Analysis 75, 190-202, 2014
52014
Comment on Cai and Betensky (2003), On the Poisson Approximation for Hazard Regression
DS Bové, L Held
Biometrics 69 (3), 795-795, 2013
22013
Improving Software Engineering in Biostatistics: Challenges and Opportunities
DS Bové, H Seibold, AL Boulesteix, J Manitz, A Gasparini, BK Guünhan, ...
arXiv preprint arXiv:2301.11791, 2023
12023
Rolling continual reassessment method with overdose control: An efficient and safe dose escalation design
J Zhu, DS Bové, Z Liao, U Beyer, G Yung, S Sarkar
Contemporary Clinical Trials, 106436, 2021
12021
A model-based view on outbreak detection
L Held, M Paul, DS Bové
Conference of Statistical Methods for Outbreak Detection, 2010
12010
The system can't perform the operation now. Try again later.
Articles 1–20